European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like New Research: The Impact of a Prebiotic August 31, 2017 Seaweed diet reveals potential for precision manipulation of gut bacteria May 10, 2018 International Research on Dietary Fiber September 2, 2017 Advancements in Prebiotics – Industry Research, Applications & Insights March 8, 2024 The enduring effects of early‐life stress on the microbiota–gut–brain axis are buffered by dietary supplementation with milk fat globule membrane and a prebiotic blend August 7, 2019 Parkinson’s disease limits short chain fatty acids production August 17, 2021
The enduring effects of early‐life stress on the microbiota–gut–brain axis are buffered by dietary supplementation with milk fat globule membrane and a prebiotic blend August 7, 2019